Market Place
Sourcing Support
Gilead declines another Arcus option after Phase 3 TIGIT fail
20 Apr 2026 //
ENDPOINTS
MSF Decries Gilead`s Revised Yeztugo Access Plan
15 Apr 2026 //
FIERCE PHARMA
PEPFAR, Global Fund expand access to Gilead’s lenacapavir
14 Apr 2026 //
BUSINESSWIRE
Global Fund Expands Commitment To Improve Access To HIV Drug
14 Apr 2026 //
REUTERS
Gilead Exercises Kymera`s KT-200 Option
09 Apr 2026 //
GLOBENEWSWIRE
Gilead Lays Off Employees At California Headquarters
03 Apr 2026 //
BIOSPACE
Gilead Extends Tender Offer to Acquire Arcellx
01 Apr 2026 //
BUSINESSWIRE
Galapagos, Gilead Partner On 1st-In-Class T Cell Engager Program
31 Mar 2026 //
GLOBENEWSWIRE
Gilead Inks Manta Pact To Dive Deeper Into Cancer Patient Aid
24 Mar 2026 //
FIERCE PHARMA
Gilead Chief Gets 20% Pay Bump, Still Falls Short Of $30M Club
24 Mar 2026 //
BIOSPACE
Gilead Boosts CEO O`Day`S 2025 Compensation By 20% To $28.4M
23 Mar 2026 //
FIERCE PHARMA
Gilead Foundation Awards $12M for HIV Prevention Programs
02 Mar 2026 //
PHARMIWEB
Gilead Sciences To Present At Upcoming Investor Conferences
23 Feb 2026 //
BUSINESSWIRE
Gilead Proactive in Deals Despite M&A`s Low Urgency Priority
11 Feb 2026 //
BIOSPACE
Gilead Sciences Unveils 2025 Full-Year Financial Results
10 Feb 2026 //
BUSINESSWIRE
Gilead Announces 3.8% Dividend Increase for Q1 2026
10 Feb 2026 //
BUSINESSWIRE
Gilead Sciences Releases Q4, FY 2025 Results on Feb. 6
27 Jan 2026 //
BUSINESSWIRE
JPM26: Gilead Captures Mood With Yezugo, HIV Data
14 Jan 2026 //
BIOSPACE
JPM26: Gilead Eyes New Deals From A `Position Of Strength`
14 Jan 2026 //
FIERCE BIOTECH
Xilio Therapeutics Highlights Upcoming Milestones
08 Jan 2026 //
GLOBENEWSWIRE
Gilead Sciences Acquires RP-3467, Pol-ATPase Inhibitor RP 3467
24 Dec 2025 //
BUSINESSWIRE
Gilead Sciences To Present At Upcoming Investor Conference
22 Dec 2025 //
BUSINESSWIRE
Gilead, U.S. Government Collaborate To Reduce Medicine Costs
19 Dec 2025 //
BUSINESSWIRE
Gilead Sciences Names Keeley Wettan as EVP, General Counsel
18 Dec 2025 //
BUSINESSWIRE
Therapy Eases Side Effects for 75% of Black Breast Cancer
10 Dec 2025 //
BUSINESSWIRE
Gilead Foundation Grants $3M For Metastatic Breast Cancer Support
09 Dec 2025 //
BUSINESSWIRE
Gilead Foundation Invests $3M To Combat Food Insecurity
24 Nov 2025 //
BUSINESSWIRE
Gilead Abruptly Parts Ways With General Counsel—Chutes & Ladders
21 Nov 2025 //
FIERCE BIOTECH
Gilead Partners For First Shipments Of Twice-Yearly Lenacapavir
18 Nov 2025 //
BUSINESSWIRE
AHF`s Mobile Billboard Calls Out Gilead`s Greed At Pharma Summit
10 Nov 2025 //
BUSINESS WIRE
Gilead Livdelzi Shows Sustained Efficacy And ALP Reduction In PBC
07 Nov 2025 //
BUSINESSWIRE
Gilead Sciences To Present At Upcoming Investor Conferences
04 Nov 2025 //
BUSINESS WIRE
Gilead Sciences Receives 2025 Prix Galien USA Award For Yeztugo
31 Oct 2025 //
BUSINESSWIRE
HOOKIPA Pharma Completes Sale Of HBV & HIV Assets To Gilead
31 Oct 2025 //
GLOBENEWSWIRE
Gilead Sciences Announces Third Quarter 2025 Financial Results
30 Oct 2025 //
BUSINESSWIRE
AHF, And 100 Organizations Stop Gilead`s Drug Price Hikes
29 Oct 2025 //
BUSINESSWIRE
80 Organizations Denounce Gilead on Price Hikes Gutting ADAP
21 Oct 2025 //
BUSINESSWIRE
Gilead Sciences To Report Q3 2025 Financial Results On October 30
09 Oct 2025 //
BUSINESSWIRE
Hanmi`s Oral Delivery Platform Compound Licensed To Gilead
29 Sep 2025 //
PR NEWSWIRE
Gilead Pumps Up Virology Pipeline With Drug Transporter Deal
29 Sep 2025 //
PR NEWSWIRE
Gilead Invests $6.5M In STEM Education In San Francisco Bay
25 Sep 2025 //
CONTRACTPHARM
CDC Strongly Recommends Gilead`s HIV PrEP Yeztugo
19 Sep 2025 //
FIERCE PHARMA
Fangzhou Wins Gilead ‘Award of Excellence’ for AI Management
17 Sep 2025 //
GLOBENEWSWIRE
Gilead Beats Whistleblower Lawsuit over Hepatitis C drugs
15 Sep 2025 //
REUTERS
Gilead Sciences Partners with Veeva Vault CRM
10 Sep 2025 //
PRESS RELEASE
Vyome Holdings Bolsters Team for Pivotal Trial Studies
09 Sep 2025 //
PHARMAWEB
US Plans to Bring Gilead HIV Drug to Market
05 Sep 2025 //
REUTERS
Gilead Urges HIV Patients to `Choose U` in Campaign
04 Sep 2025 //
FIERCE PHARMA
Gilead Starts Construction on Development & Manufacturing Center
04 Sep 2025 //
CONTRACTPHARMA
Gilead Partners PEPFAR for Biannual Lenacapavir Supply
04 Sep 2025 //
BUSINESSWIRE
Gilead breaks ground on production hub as part of $32B US outlay
04 Sep 2025 //
FIERCE PHARMA
Gilead Breaks Ground on Production Hub as Part of $32B US Outlay
03 Sep 2025 //
FIERCE PHARMA
Gilead`s Kite Erodes $2.3B Shoreline Cell Therapy Deal
03 Sep 2025 //
FIERCE BIOTECH
CVS Denies Coverage for Gilead`s Biannual PrEP Drug Yeztugo
21 Aug 2025 //
FIERCE PHARMA
Gilead Sciences to Attend Future Investor Conferences
20 Aug 2025 //
BUSINESSWIRE
Gilead Reports 7% Sales Decline for CAR-T`s Yescarta, Tecartus
12 Aug 2025 //
FIERCE PHARMA
Gilead Confident in PrEP Despite Task Force Uncertainty
08 Aug 2025 //
BIOSPACE
Gilead Sciences Reveals Q2 2025 Financial Results
07 Aug 2025 //
BUSINESSWIRE
EU Backs Gilead`s Twice-Yearly Injection for HIV Prevention
25 Jul 2025 //
REUTERS
Gilead Sciences to Release Second Quarter 2025 Financial Results
24 Jul 2025 //
BUSINESSWIRE
